CVS Health Statistics Share Statistics CVS Health has 1.27B
shares outstanding. The number of shares has increased by 0.56%
in one year.
Shares Outstanding 1.27B Shares Change (YoY) 0.56% Shares Change (QoQ) 0.33% Owned by Institutions (%) 84.37% Shares Floating 1.27B Failed to Deliver (FTD) Shares 7 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 13.67M, so 1.08% of the outstanding
shares have been sold short.
Short Interest 13.67M Short % of Shares Out 1.08% Short % of Float 1.09% Short Ratio (days to cover) 2.15
Valuation Ratios The PE ratio is 12.25 and the forward
PE ratio is 9.21.
CVS Health's PEG ratio is
-0.28.
PE Ratio 12.25 Forward PE 9.21 PS Ratio 0.15 Forward PS 0.2 PB Ratio 0.75 P/FCF Ratio 8.93 PEG Ratio -0.28
Financial Ratio History Enterprise Valuation CVS Health has an Enterprise Value (EV) of 130.85B.
EV / Sales 0.35 EV / EBITDA 9.56 EV / EBIT 14.37 EV / FCF 20.68
Financial Position The company has a current ratio of 0.81,
with a Debt / Equity ratio of 1.1.
Current Ratio 0.81 Quick Ratio 0.6 Debt / Equity 1.1 Debt / EBITDA 6.06 Debt / FCF 13.11 Interest Coverage 2.88
Financial Efficiency Return on Equity is 6.11% and Return on Invested Capital is 3.61%.
Return on Equity 6.11% Return on Assets 1.82% Return on Invested Capital 3.61% Revenue Per Employee $1.7M Profits Per Employee $21.07K Employee Count 219,000 Asset Turnover 1.47 Inventory Turnover 17.75
Taxes Income Tax 1.56B Effective Tax Rate 25.41%
Stock Price Statistics The stock price has increased by 16.31% in the
last 52 weeks. The beta is 0.59, so CVS Health's
price volatility has been higher than the market average.
Beta 0.59 52-Week Price Change 16.31% 50-Day Moving Average 64.52 200-Day Moving Average 60.61 Relative Strength Index (RSI) 59.04 Average Volume (20 Days) 8,469,016
Income Statement In the last 12 months, CVS Health had revenue of 372.81B
and earned 4.61B
in profits. Earnings per share was 3.66.
Revenue 372.81B Gross Profit 51.4B Operating Income 8.52B Net Income 4.61B EBITDA 13.68B EBIT 9.11B Earnings Per Share (EPS) 3.66
Full Income Statement Balance Sheet The company has 8.59B in cash and 82.92B in
debt, giving a net cash position of -74.33B.
Cash & Cash Equivalents 8.59B Total Debt 82.92B Net Cash -74.33B Retained Earnings 62.84B Total Assets 258.34B Working Capital -18.51B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 9.11B
and capital expenditures -2.78B, giving a free cash flow of 6.33B.
Operating Cash Flow 9.11B Capital Expenditures -2.78B Free Cash Flow 6.33B FCF Per Share 5.02
Full Cash Flow Statement Margins Gross margin is 13.79%, with operating and profit margins of 2.28% and 1.24%.
Gross Margin 13.79% Operating Margin 2.28% Pretax Margin 1.65% Profit Margin 1.24% EBITDA Margin 3.67% EBIT Margin 2.28% FCF Margin 1.7%
Dividends & Yields CVS pays an annual dividend of $3.33,
which amounts to a dividend yield of 4.35%.
Dividend Per Share $3.33 Dividend Yield 4.35% Dividend Growth (YoY) 0% Payout Ratio 92.62% Earnings Yield 8.16% FCF Yield 11.19%
Dividend Details Analyst Forecast The average price target for CVS is $78,
which is 20.2% higher than the current price. The consensus rating is "Buy".
Price Target $78 Price Target Difference 20.2% Analyst Consensus Buy Analyst Count 16
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $18.3 Lynch Upside -71.81% Graham Number 70.35 Graham Upside 8.38%
Stock Splits The last stock split was on Jun 7, 2005. It was a
forward
split with a ratio of 2:1.
Last Split Date Jun 7, 2005 Split Type forward Split Ratio 2:1
Scores Altman Z-Score 2.15 Piotroski F-Score 6
